Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by ...

Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...

In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

Researchers from ICTER have developed a fragment-based drug discovery method combined with microcrystal electron diffraction to design enzyme inhibitors at atomic resolution. The approach aims to ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

A designer drug described as 10 times more potent than fentanyl is causing an uptick in U.S. overdoses, according to health officials in multiple states. Known as cychlorphine, the synthetic opioid is ...